Panitumumab Plus Modified FOLFOX or Panitumumab Plus Fluorouracil and Leucovorin as Initial Treatment for Elderly Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by GONO Foundation
J. Clin. Oncol 2023 Aug 03;[EPub Ahead of Print], S Lonardi, C Rasola, R Lobefaro, D Rossini, V Formica, M Scartozzi, GL Frassineti, G Boscolo, S Cinieri, S Di Donato, N Pella, F Bergamo, A Raimondi, E Arnoldi, L Antonuzzo, C Granetto, F Zustovich, M Ronzoni, S Leo, F Morano, F Loupakis, F Buggin, V Zagonel, M Fassan, C Cremolini, L Boni, F PietrantonioFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.